Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
CiplaMed 2.0 leverages advanced analytics and automation
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
The product basket increased to 1800 medicines and 285 Surgical Equipment
Subscribe To Our Newsletter & Stay Updated